These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 15140332
21. High prevalence of hepatitis C virus but not HIV co-infection among patients with tuberculosis in Georgia. Richards DC, Mikiashvili T, Parris JJ, Kourbatova EV, Wilson JC, Shubladze N, Tsertvadze T, Khechinashvili G, del Rio C, Blumberg HM. Int J Tuberc Lung Dis; 2006 Apr; 10(4):396-401. PubMed ID: 16602403 [Abstract] [Full Text] [Related]
22. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA. Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274 [Abstract] [Full Text] [Related]
23. The economic burden of lung cancer and the associated costs of treatment failure in the United States. Kutikova L, Bowman L, Chang S, Long SR, Obasaju C, Crown WH. Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249 [Abstract] [Full Text] [Related]
24. Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a Medicare managed care population. Bhosle MJ, Reardon G, Camacho FT, Anderson RT, Balkrishnan R. Am J Geriatr Pharmacother; 2007 Jun; 5(2):100-11. PubMed ID: 17719512 [Abstract] [Full Text] [Related]
25. Budget impact of tegaserod on a managed care organization formulary. Bloom MA, Barghout V, Kahler KH, Bentkover J, Kurth H, Gralnek IM, Spiegel BM. Am J Manag Care; 2005 Apr; 11(1 Suppl):S27-34. PubMed ID: 15926761 [Abstract] [Full Text] [Related]
26. What is the cost-effectiveness of hepatitis C treatment for injecting drug users on methadone maintenance in New Zealand? Sheerin IG, Green FT, Sellman JD. Drug Alcohol Rev; 2004 Sep; 23(3):261-72. PubMed ID: 15370005 [Abstract] [Full Text] [Related]
27. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India. Tripathi AK, Khanna M, Gupta N, Chandra M. J Assoc Physicians India; 2007 Jun; 55():429-31. PubMed ID: 17879496 [Abstract] [Full Text] [Related]
29. Adding HCV treatment to HIV treatment in HIV-HCV coinfected patients: the impact on the different dimensions of fatigue and self-reported side effects. Marcellin F, Préau M, Dellamonica P, Ravaux I, Kurkdji P, Protopopescu C, Carrieri MP, Spire B. J Pain Symptom Manage; 2007 Oct; 34(4):413-21. PubMed ID: 17616331 [Abstract] [Full Text] [Related]
31. Costs of care for HIV infection in a managed care population from 1995 to 1997. Lapins DL, Urdaneta ME, Barrett J, Hamel EC, Duong PT, Markson LE. Am J Manag Care; 2000 Sep; 6(9):973-81. PubMed ID: 11184068 [Abstract] [Full Text] [Related]
32. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach. Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA. Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731 [Abstract] [Full Text] [Related]